Kovo HealthTech Announces Appointment of Robert Galarza to Board of Directors
Kovo HealthTech Announces Appointment of Robert Galarza to Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - March 7, 2024) - Kovo HealthTech Corporation (TSXV: KOVO) (the "Company" or "Kovo") — a leader in healthcare Billing-as-a-Service — today announced the appointment of Robert Galarza to the Kovo HealthTech Corporation Board of Directors, effective February 9th, 2024. Following the appointment of Mr. Galarza, the Board will comprise 5 directors, 3 of whom are independent.
不列顛哥倫比亞省溫哥華--(Newsfile Corp.,2024 年 3 月 7 日)-Kovo HealthTech Corporation(多倫多證券交易所代碼:KOVO)(公司“或”科沃“)——醫療計費即服務領域的領導者——今天宣佈任命Robert Galarza爲Kovo HealthTech公司董事會成員,自2月9日起生效第四,2024。Galarza先生被任命後,董事會將由5名董事組成,其中3名是獨立董事。
"Robert is an excellent addition to the Kovo board of directors and we look forward to adding his experience, wisdom, common sense and business acumen to the team," said Kovo CEO Greg Noble.
Kovo首席執行官Greg Noble表示:“Robert是Kovo董事會的出色成員,我們期待着將他的經驗、智慧、常識和商業頭腦加入團隊。”
Robert Galarza, 45, currently holds an executive leadership position within a family of companies developing personalized, curated healthcare programs using best-in-class tools for physical and mental health and wellness. Mr. Galarza is the former CEO of TruTrace Technologies, Inc., which developed the first integrated blockchain platform to register and track intellectual property for the global medical cannabis market. Focused on transparency through collaboration and granular inventory data, TruTrace helped Canada's largest pharmacy chain and health research organization launch a first of its kind real-world evidence study utilizing blockchain to track variabilities of medical products and connecting this data to patients. Mr. Galarza spent several years as a corporate transactional attorney after an early career in advertising and mass media communications and has spent the last decade dedicated to digital technology, specifically focusing on mobile platform development, software-as-a-service (SaaS) solutions and blockchain.
現年45歲的羅伯特·加拉爾扎目前在一個使用一流工具開發個性化、精心策劃的醫療保健計劃的公司中擔任行政領導職務,這些計劃使用一流的工具促進身心健康和保健。加拉爾扎先生是TruTrace Technologies, Inc. 的前首席執行官,該公司開發了第一個集成區塊鏈平台,用於註冊和跟蹤全球醫用大麻市場的知識產權。TruTrace專注於通過協作和精細庫存數據提高透明度,幫助加拿大最大的連鎖藥房和健康研究組織啓動了首個利用區塊鏈跟蹤醫療產品的變異性並將這些數據與患者聯繫起來的真實世界證據研究。Galarza先生在從事廣告和大衆媒體傳播的早期職業生涯後,曾擔任公司交易律師多年,在過去十年中一直致力於數字技術,特別專注於移動平台開發、軟件即服務(SaaS)解決方案和區塊鏈。
About Kovo HealthTech Corporation
關於 Kovo 健康科技公司
Kovo HealthTech Corporation is a growing healthcare technology company that specializes in Billing-as-a-Service offering SaaS-style recurring revenue contracts and software for more than 1700 US healthcare providers. Kovo helps healthcare providers digitally track and manage complex patient care registration, services, billing and payments in a seamless way, using its industry-leading OneRev technology platform. Currently, through its clients, Kovo processes over $250 million CAD ($200M USD) in annual billing transactions for more than 4.5 million patients. By offering effective billing practices and technology through long-term SaaS-style contracts, Kovo helps healthcare practitioners get paid so they can focus on offering quality care. To learn more about Kovo and to keep up-to-date on Kovo news, visit .
Kovo HealthTech Corporation是一家成長中的醫療保健技術公司,專門從事計費即服務,爲1700多家美國醫療保健提供商提供SaaS式的經常性收入合同和軟件。Kovo 使用其行業領先的 OneRev 技術平台,幫助醫療保健提供商以數字方式無縫跟蹤和管理複雜的患者護理登記、服務、賬單和付款。目前,Kovo通過其客戶爲超過450萬名患者處理超過2.5億加元(合2億美元)的年度賬單交易。通過長期的SaaS式合同提供有效的計費做法和技術,Kovo幫助醫療保健從業人員獲得報酬,使他們能夠專注於提供優質的醫療服務。要了解有關Kovo的更多信息並了解Kovo的最新新聞,請訪問。
For more information:
Greg Noble, CEO
investors@kovo.co
1-866-558-6777
欲了解更多信息:
首席執行官格雷格諾布爾
investors@kovo.co
1-866-558-6777
Forward-Looking Information and Statements
前瞻性信息和陳述
This press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") concerning the Company and its subsidiaries within the meaning of applicable securities laws. Forward-looking information may relate to the future financial outlook and anticipated events or results of the Company and may include information regarding the Company's financial position, business strategy, growth strategies, acquisition prospects and plans, addressable markets, budgets, operations, financial results, taxes, dividend policy, plans and objectives. Particularly, information regarding the Company's expectations of future results, performance, achievements, prospects or opportunities or the markets in which the Company operates is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects", "budgets", "scheduled", "estimates", "outlook", "forecasts", "projects", "prospects", "strategy", "intends", "anticipates", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", or "will" occur. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates and projections regarding future events or circumstances.
本新聞稿包含適用證券法所指的有關公司及其子公司的 “前瞻性信息” 和 “前瞻性陳述”(統稱爲 “前瞻性信息”)。前瞻性信息可能與公司的未來財務前景和預期事件或業績有關,可能包括有關公司財務狀況、業務戰略、增長戰略、收購前景和計劃、潛在市場、預算、運營、財務業績、稅收、股息政策、計劃和目標的信息。特別是,有關公司對未來業績、業績、成就、前景或機遇或公司運營所在市場的預期的信息是前瞻性信息。在某些情況下,前瞻性信息可以通過使用前瞻性術語來識別,例如 “計劃”、“目標”、“預期”、“預算”、“預期”、“估計”、“展望”、“預測”、“項目”、“前景”、“戰略”、“打算”、“預期”、“相信”,或者某些行動、事件或結果 “可能” 的詞語或陳述的變體,可能”、“會”、“可能” 或 “將” 發生。此外,任何提及對未來事件或情況的預期、意圖、預測或其他描述的陳述都包含前瞻性信息。包含前瞻性信息的陳述不是歷史事實,而是代表管理層對未來事件或情況的預期、估計和預測。
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance, or achievements that may be expressed or implied by such forward-looking information, including, without limitation, those listed in the "Risk Factors" section of the final prospectus of the Company dated May 26, 2021. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance, or achievements could vary materially from those expressed or implied by the forward-looking statements contained in this press release. Forward-looking information, by its nature, is based on the Company's opinions, estimates and assumptions in light of management's experience and perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate and reasonable in the circumstances. Those factors should not be construed as exhaustive. Despite a careful process to prepare and review forward-looking information, there can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. These factors should be considered carefully, and readers should not place undue reliance on the forward-looking information. Although the Company bases its forward-looking information on assumptions that it believes were reasonable when made, which include, but are not limited to, assumptions with respect to the Company's future growth potential, results of operations, future prospects and opportunities, execution of the Company's business strategy, there being no material variations in the current tax and regulatory environments, future levels of indebtedness and current economic conditions remaining unchanged, the Company cautions readers that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industry in which the Company operates may differ materially from the forward-looking statements contained in this press release. In addition, even if the Company's results of operations, financial condition and liquidity, and the development of the industry in which it operates are consistent with the forward-looking information contained in this press release, those results or developments may not be indicative of results or developments in subsequent periods. This press release makes reference to certain non-IFRS measures. These measures are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. The Company's definitions of non-IFRS measures used in this release may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS. The Company uses non-IFRS financial measures, including "ARR**", "EBITDA", "Adjusted EBITDA*" and "Adjusted EBITDA Margin" to provide investors with supplemental measures of its operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. "EBITDA" means net income (loss) before amortization and depreciation expenses, finance and interest costs, and provision for income taxes. *"Adjusted EBITDA" adjusts EBITDA for stock-based compensation expense, transactional gains or losses on assets, asset impairment charges, interest income, net foreign exchange gains or losses, income tax expense or recovery, forgivable one-time government financial payments related to the COVID-19 pandemic ("PPP Loans"), and any transactional expenses. Specifically, the Company believes that Adjusted EBITDA, when viewed with the Company's results under IFRS and the accompanying reconciliations, provides useful information about the Company's business without regard to potential distortions. By eliminating potential differences in results of operations between periods caused by factors such as depreciation and amortization methods and restructuring, impairment and other charges, the Company believes that Adjusted EBITDA can provide a useful additional basis for comparing the current performance of the underlying operations being evaluated. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of issuers. The Company's management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period.
許多因素可能導致公司的實際業績、業績或成就與此類前瞻性信息可能表達或暗示的任何未來業績、業績或成就存在重大差異,包括但不限於2021年5月26日公司最終招股說明書的 “風險因素” 部分中列出的業績、業績或成就。如果其中一項或多項風險或不確定性成爲現實,或者前瞻性陳述所依據的假設被證明不正確,則實際結果、業績或成就可能與本新聞稿中包含的前瞻性陳述所表達或暗示的結果存在重大差異。就其性質而言,前瞻性信息基於公司的觀點、估計和假設,這些觀點是管理層的經驗和對歷史趨勢、當前狀況和預期未來發展的看法,以及公司目前認爲在當時情況下適當和合理的其他因素。不應將這些因素解釋爲詳盡無遺。儘管準備和審查前瞻性信息的過程非常謹慎,但無法保證基本觀點、估計和假設會被證明是正確的。應仔細考慮這些因素,讀者不應過分依賴前瞻性信息。儘管公司基於其認爲合理的假設來提供前瞻性信息,包括但不限於對公司未來增長潛力、經營業績、未來前景和機會、公司業務戰略的執行、當前稅收和監管環境沒有實質性變化、未來負債水平和當前經濟狀況保持不變的假設,但公司提醒讀者,前瞻性陳述並非如此對未來業績的保證,以及我們的實際經營業績、財務狀況和流動性以及公司運營行業的發展可能與本新聞稿中包含的前瞻性陳述存在重大差異。此外,即使公司的經營業績、財務狀況和流動性以及其經營所在行業的發展與本新聞稿中包含的前瞻性信息一致,這些業績或發展也可能不代表後續時期的業績或發展。本新聞稿提到了某些非國際財務報告準則指標。這些衡量標準不是《國際財務報告準則》認可的衡量標準,不具有《國際財務報告準則》規定的標準化含義,因此不太可能與其他公司提出的類似衡量標準相提並論。相反,這些指標是作爲額外信息提供的,目的是從管理層的角度進一步了解公司的經營業績,從而對這些國際財務報告準則指標進行補充。公司在本新聞稿中使用的非國際財務報告準則指標的定義可能與其他公司在報告中使用的此類指標的定義不同。非國際財務報告準則指標作爲分析工具存在侷限性,不應孤立地考慮,也不能替代對根據國際財務報告準則報告的公司財務信息的分析。公司使用非國際財務報告準則財務指標,包括 “ARR**”、“息稅折舊攤銷前利潤”、“調整後息稅折舊攤銷前利潤率*” 和 “調整後息稅折舊攤銷前利潤率”,爲投資者提供經營業績的補充衡量標準,剔除對經營業績或運營狀況影響較小的項目,從而突出其核心業務中僅依賴國際財務報告準則財務指標時可能不明顯的趨勢。“息稅折舊攤銷前利潤” 是指扣除攤銷和折舊費用、財務和利息成本以及所得稅準備金前的淨收益(虧損)。* “調整後息稅折舊攤銷前利潤” 調整股票薪酬支出、資產交易損益、資產減值費用、利息收入、淨外匯收益或虧損、所得稅支出或回收、與 COVID-19 疫情相關的可免除的一次性政府財政支出(“PPP貸款”)以及任何交易支出的息稅折舊攤銷前利潤。具體而言,公司認爲,調整後的息稅折舊攤銷前利潤,與公司根據國際財務報告準則取得的業績和隨之而來的對賬來看,不考慮潛在的扭曲,可以提供有關公司業務的有用信息。通過消除折舊和攤銷方法以及重組、減值和其他費用等因素造成的各期經營業績的潛在差異,公司認爲,調整後的息稅折舊攤銷前利潤可以爲比較正在評估的基礎業務的當前業績提供有用的額外基礎。該公司認爲,證券分析師、投資者和其他利益相關方在評估發行人時經常使用非國際財務報告準則的財務指標。公司管理層還使用非國際財務報告準則財務指標,以促進不同時期的經營業績比較。
Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as of the date made (or as of the date they are otherwise stated to be made). Any forward-looking statement that is made in this press release speaks only as of the date of such statement.
儘管公司試圖確定可能導致實際業績與前瞻性信息中包含的業績存在重大差異的重要風險因素,但可能還有其他風險因素,公司目前不知道,或者公司目前認爲不是重大風險因素,也可能導致實際業績或未來事件與此類前瞻性信息中表達的結果存在重大差異。無法保證此類信息會被證明是準確的,因爲實際結果和未來事件可能與此類信息中的預期存在重大差異。因此,讀者不應過分依賴前瞻性信息,前瞻性信息僅代表截至發佈日期(或截至其他聲明發布之日)。本新聞稿中的任何前瞻性陳述僅代表截至該聲明發布之日。
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。